71 related articles for article (PubMed ID: 21325260)
1. 5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignancies.
Wong JC; Weinfurtner KM; Westover T; Kim J; Lebish EJ; Del Pilar Alzamora M; Huang BJ; Walsh M; Abdelhamed S; Ma J; Klco JM; Shannon K
Leukemia; 2024 May; 38(5):1182-1186. PubMed ID: 38443608
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia.
Higgins A; Shah MV
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32640569
[TBL] [Abstract][Full Text] [Related]
3. Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia.
Eldfors S; Saad J; Ikonen N; Malani D; Vähä-Koskela M; Gjertsen BT; Kontro M; Porkka K; Heckman CA
Blood Adv; 2024 Apr; 8(7):1621-1633. PubMed ID: 38197948
[TBL] [Abstract][Full Text] [Related]
4. Rapid progression from MDS to AML with gastric submucosal tumour as an extramedullary infiltration.
Kobayashi K; Umekawa Y
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38565228
[TBL] [Abstract][Full Text] [Related]
5. The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy.
Buckley SA; Othus M; Estey EH; Walter RB
Blood Cancer J; 2015 Jan; 5(1):e276. PubMed ID: 25635529
[No Abstract] [Full Text] [Related]
6. Bone marrow niches in myelodysplastic syndromes.
Tosato G; Feng JX; Ohnuki H; Sim M
J Cancer Metastasis Treat; 2021; 7():. PubMed ID: 34746416
[TBL] [Abstract][Full Text] [Related]
7. [Secondary myelodysplastic syndrome in a patient with
Lin D; Zhang GJ; Mi YC; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2018 Jan; 39(1):50-52. PubMed ID: 29551034
[No Abstract] [Full Text] [Related]
8. Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML.
Herold S; Sockel K; Sayehli C; Herbst R; Dührsen U; Oelschlägel U; Böttner A; Hindahl H; Kullmer J; Helas S; Sauer M; Mohr B; Mies A; Bornhäuser M; Ehninger G; Röllig C; Thiede C; Platzbecker U
Leukemia; 2017 Oct; 31(10):2247-2251. PubMed ID: 28690314
[No Abstract] [Full Text] [Related]
9. Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML.
Wong TN; Miller CA; Klco JM; Petti A; Demeter R; Helton NM; Li T; Fulton RS; Heath SE; Mardis ER; Westervelt P; DiPersio JF; Walter MJ; Welch JS; Graubert TA; Wilson RK; Ley TJ; Link DC
Blood; 2016 Feb; 127(7):893-7. PubMed ID: 26631115
[TBL] [Abstract][Full Text] [Related]
10. T-cell Acute Lymphoblastic Leukemia with del (7) (q11.2q22) and Aberrant Expression of Myeloid Markers.
Ahmadzadeh A; Saedi S; Jaseb K; Asnafi AA; Alghasi A; Saki N
Int J Hematol Oncol Stem Cell Res; 2013; 7(4):40-4. PubMed ID: 24505542
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related myeloid neoplasms in 39 Korean patients: a single institution experience.
Huh HJ; Lee SH; Yoo KH; Sung KW; Koo HH; Kim K; Jang JH; Jung C; Kim SH; Kim HJ
Ann Lab Med; 2013 Mar; 33(2):97-104. PubMed ID: 23483787
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).
Kanagal-Shamanna R; Yin CC; Miranda RN; Bueso-Ramos CE; Wang XI; Muddasani R; Medeiros LJ; Lu G
Cancer Genet; 2013; 206(1-2):42-6. PubMed ID: 23357231
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine.
Arana-Yi C; Block AW; Sait SN; Ford LA; Barcos M; Baer MR
Leuk Res; 2008 Jul; 32(7):1043-8. PubMed ID: 18093651
[TBL] [Abstract][Full Text] [Related]
14. Translocation (7;9)(q22;q34) in therapy-related myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloblastic leukemia.
Yamamoto K; Yakushijin K; Kawamori Y; Minagawa K; Katayama Y; Matsui T
Cancer Genet Cytogenet; 2007 Jul; 176(1):61-6. PubMed ID: 17574966
[TBL] [Abstract][Full Text] [Related]
15. Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
Cho JH; Hur M; Moon HW; Yun YM; Ko YS; Kim WS; Lee MH
Hum Pathol; 2012 Apr; 43(4):605-9. PubMed ID: 22036054
[TBL] [Abstract][Full Text] [Related]
16. Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML.
Kim YG; Cho SY; Park TS; Oh SH; Yoon HJ
Ann Clin Lab Sci; 2011; 41(1):79-83. PubMed ID: 21325260
[TBL] [Abstract][Full Text] [Related]
17. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]